Rosiglitazone reverses insulin secretion altered by chronic exposure to free fatty acid via IRS-2-associated phosphatidylinositol 3-kinase pathway.
Year: 2003
Type: article
Source: PubMed
Authors: Li Yang, Han-Xiang An, Xiu-Ling Deng, Lu-Lu Chen, Zhuo-Ya Li
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2386674668
